Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy

被引：0
|
作者：
Ahn, J.
Kim, S.
Ahn, M.
Lee, J.
Uhm, J.
Sun, J.
Park, K.
Park, Y.
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.7551
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7551
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Comparison of erlotinib (Tarceva™) versus gefitinib (Iressa®) as the second line therapy for the treatment of advanced non-small cell lung cancer patients: a randomized phase II trial
    Uhm, Ji Eun
    Sun, Jong Mu
    Lee, Soo Hyeon
    Kong, Jee Hyun
    Yun, Jin A.
    Lee, Sang Mi
    Lee, Jeeyun
    Park, Yeon Hee
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S292 - S292
  • [22] A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-Naive Patients with Advanced Non-Small Cell Lung Cancer
    Lind, Joline S. W.
    Dingemans, Anne-Marie C.
    Groen, Harry J. M.
    Thunnissen, Frederik B.
    Bekers, Otto
    Heideman, Danielle A. M.
    Honeywell, Richard J.
    Giovannetti, Elisa
    Peters, Godefridus J.
    Postmus, Pieter E.
    van Suylen, Robert Jan
    Smit, Egbert F.
    CLINICAL CANCER RESEARCH, 2010, 16 (11) : 3078 - 3087
  • [23] Phase I/II study of gefitinib in combination with vorinostat in patients with advanced non-small cell lung cancer (NSCLC) who progressed on prior chemotherapy
    Han, Ji-Youn
    Lee, Soo Hyun
    Yun, Tak
    Lee, Young Jooo
    Hwang, Kum Hui
    Ryu, Sunah
    Kim, Heung Tae
    Lee, Jin Soo
    CANCER RESEARCH, 2014, 74 (19)
  • [24] Phase II study of erlotinib for chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doublets
    Lee, Dae Ho
    Kim, Sang-We
    Suh, Cheolwon
    Han, Yun Hee
    Lee, Jung-Shin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (01) : 35 - 39
  • [25] Phase II study of docetaxel plus gemcitabine in patients with non-small cell lung cancer (NSCLC) that failed previous chemotherapy (CT).
    Chen, YM
    Perng, RP
    Whang-Peng, J
    Lin, WC
    Wu, HW
    Tsai, CM
    ANNALS OF ONCOLOGY, 2000, 11 : 115 - 115
  • [26] Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib
    Cho, Byoung Chul
    Im, Chong-Kun
    Park, Moo-Suk
    Kim, Se Kyu
    Chang, Joon
    Park, Jong Pil
    Choi, Hye Jin
    Kim, Yu Jin
    Shin, Sang-Joon
    Sohn, Joo Hyuk
    Kim, Hoguen
    Kim, Joo Hang
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18) : 2528 - 2533
  • [27] A Randomized, Phase II Study of Nimotuzumab Plus Gefitinib vs Gefitinib in Advanced Non-Small Cell Lung Cancer After Platinum-Based Chemotherapy
    Kim, Hye Ryun
    Jang, Joung Soon
    Sun, Jong-Mu
    Ahn, Myung-Ju
    Kim, Dong-Wan
    Jung, Inkyung
    Moon, Yong-Wha
    Lim, Sun Min
    Jeong, Jae Heon
    Lee, Ki Hyeong
    Kim, Joo-Hang
    Lee, Dae Ho
    Kim, Sang-We
    Cho, Byoung Chul
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S663 - S664
  • [28] A randomized phase II trial of erlotinib or erlotinib and bevacizumab in patients with advanced EGFR mutant non-small cell lung cancer (NSCLC)
    Stinchcombe, T. E.
    Janne, P. A.
    Wang, X.
    Bertino, E. M.
    Weiss, J. M.
    Bazhenova, L.
    Gu, L.
    Lau, C. J.
    Paweletz, C. P.
    Jaslowski, A. J.
    Gerstner, G. J.
    Baggstrom, M. Q.
    Graziano, S. L.
    Beardenlii, J.
    Vokes, E. E.
    ANNALS OF ONCOLOGY, 2018, 29 : 522 - 522
  • [29] Erlotinib after failure of gefitinib in patients with advanced non-small cell lung cancer previously responding to gefitinib
    Vasile, Enrico
    Tibaldi, Carmelo
    Chella, Antonio
    Falcone, Alfredo
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) : 912 - 914
  • [30] Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study
    Giaccone, Giuseppe
    Ruiz, Marielle Gallegos
    Le Chevalier, Thierry
    Thatcher, Nick
    Smit, Egbert
    Rodriguez, Jose Antonio
    Janne, Pasi
    Oulid-Aissa, Dalila
    Soria, Jean-Charles
    CLINICAL CANCER RESEARCH, 2006, 12 (20) : 6049 - 6055
12345